Latest News | BIZ-VACCINE-J&J Johnson & Johnson Exploring Ways to Accelerate Delivery of Its COVID Vaccine in India
Get latest articles and stories on Latest News at LatestLY. Johnson & Johnson on Tuesday said it is in talks with the Indian government to explore ways to accelerate delivery of its single dose COVID-19 vaccine in the country.
New Delhi, Jun 29 (PTI) Johnson & Johnson on Tuesday said it is in talks with the Indian government to explore ways to accelerate delivery of its single dose COVID-19 vaccine in the country.
The company also said as per a recent announcement by the Indian drug regulator, there is no longer a need to conduct bridging clinical trials of COVID-19 vaccines in India.
"We are in ongoing discussions with the Government of India and are exploring how best to accelerate our ability to deliver the Johnson & Johnson single dose COVID-19 vaccine to the people of India," Johnson & Johnson India spokesperson said in a statement.
As per the recent announcement by the Drugs Controller General of India (DCGI), there is no longer a requirement to conduct bridging clinical studies of COVID-19 vaccines in India, the statement added.
On June 2, DCGI had waived the requirement of testing every batch of foreign-made COVID-19 vaccines by the Central Drugs Laboratory, Kasauli and post-approval bridging trials for such firms if the vaccine batch/lot has been certified and released by National Control Laboratory of the country of origin.
DCGI on Tuesday granted permission to Mumbai-based pharma major Cipla to import Moderna's COVID-19 vaccine for restricted use in the country.
Moderna's vaccine will be the fourth COVID-19 jab available in India after Covishield, Covaxin and Sputnik V.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)